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CD-RAP/MIA - a marker of chondrogenesis in equine bone marrow-
derived mesenchymal stem cells
L.C. Berg, P.D. Thomsen;
Dep. Of Animal And Veterinary Basic Sciences, University of 
Copenhagen, Faculty of Life Sciences, Frederiksberg C, Denmark
Purpose: Studies have shown that equine adult mesenchymal 
stem cells (MSCs) can differentiate into chondrogenic cells for the 
potential treatment of injured articular cartilage. CD-RAP (cartilage 
derived retinoic acid sensitive protein) / MIA (melanoma inhibitory 
activity) is a small protein secreted by chondrocytes. CD-RAP/MIA 
is therefore available for analysis in the culture medium making it 
possible to monitor the chondrogenic process without disturbing 
the cells. A previous study showed that human MSCs differentiated 
into chondrogenic cells expressed CD-RAP/MIA. The aim of this 
study was to evaluate CD-RAP/MIA as a marker of chondrogenesis 
in equine bone marrow-derived MSCs. 
Methods and Materials: Equine MSCs were isolated from bone 
NBSSPX DPMMFDUFE XJUIJO ¾WF NJOVUFT QPTUFVUIBOBTJB 4FDPOE
passage MSCs were seeded in pellets of 106 cells and chondrogenesis 
was induced by culturing pellets for 32 days in chondrogenic culture 
medium containing transforming growth factor ȕ~1~ (TGF-ȕ~1~) or 
a combination of TGF-ȕ~1~ and insulin-like growth factor 1 (IGF-1). 
Medium was changed every three days and collected for analysis. 
After 32 days the pellets were collected and processed for histology 
or RNA isolation. 
Results: Histological analysis showed chondrogenic morphology 
with increased chondrogenesis in cultures supplemented with both 
TGF-ȕ~1~ and IGF-1. RT-PCR analysis showed mRNA expression of 
CD-RAP/MIA and Collagen type 2. Western blot analysis showed 
presence of CD-RAP/MIA in the culture medium starting from day 
21. 
Conclusions: The results of this study indicate that CD-RAP/MIA has 
potential as a marker of chondrogenesis in equine bone marrow-
derived MSCs and possibly other types of equine stem cells. 
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Perturbation b-catenin signaling in the chondrogenic process 
of mesenchymal stem cells for the generation of phenotypically 
stable cartilage tissue
Z. Yang, T.M. Liu, J.H.P. Hui, E.H. Lee;
Orthopaedic Surgery Department, Tissue Engineering Program, 
National University Singapore, Singapore, Singapore
Purpose: Human mesenchymal stem cells (MSCs) have the potential 
to undergo full span chondrogenic differentiation resembling 
FOEPDIPOESBM PTTJ¾DBUJPO &GGFDUJWF VTF PG .4$T JO DFMMCBTFE
therapy for articular cartilage tissue engineering depends hugely 
on derivation of phenotypically stable hyaline cartilage. This study 
investigates the effect of temporal perturbation of b-catenin signaling 
on TGFb-induced MSC chondrogenic differentiation. 
Methods and Materials: MSCs derived from human bone marrow 
were induced to undergo chondrogenic differentiation in a high 
density pellet system in the presence of TGFb3. Effect of activating 
or inhibiting the b-catenin pathway was achieved by inclusion of 
agonist and antagonist. The stages of chondrogenic differentiation 
were analysed for glycosaminoglycans, type II and type X collagen 
formation by Alcian blue and immunohistochemical staining and 
GVSUIFSDPO¾SNFECZSFBMUJNF1$3BOBMZTJT
Results: Activation of b-catenin signaling elevated the chondrogenic 
effect of TGFb, resulting in the up-regulated expression of sGAG and 
type II collagen, and hypertrophic development of the chondrogenic 
cells. On the other hand, antagonist of b-catenin dose-dependently 
inhibits the effect of TGFb-initiation of MSC chondrogenesis. When 
added after the MSC had undergone initial chondrogenesis, b-
catenin antagonist exerted the effect of reducing the hypertrophy 
maturation of chondrocytes. 
Conclusions: Our data suggests that TGFb-induced MSC 
chondrogenesis is dependent on the b-catenin signaling activation. 
Prolonged activation of b-catenin signaling can, however, lead to 
hypertrophic differentiation of MSC-derived chondrocytes, which 
can be inhibited by inclusion of antagonist at the appropriate time 
during the process of differentiation. By perturbation of the b-catenin 
pathway, preservation of the chondrocytes at the pre-hypertrophy 
stage might be achievable. 
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1Research Center On Osteoarticular And Dental Tissue Engineering, 
UMR S/Inserm U791, Nantes, France, 2Inserm U791 Lioad Laboratory 
Of Osteoarticular And Dental Tissue Engineering, University of 
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Purpose: Human adipose tissue-derived stem cells (hATSC) have 
recently been contemplated as potential reparative cells for cartilage 
tissue engineering. Chondrogenic differentiation of hATSC can be 
induced by the combination of enriched culture medium and a three 
dimensional (3D) environment. Given that cartilage is avascular, oxygen 
tension has also been suggested as a regulatory factor of chondrocyte 
differentiation. Our work aimed at determining the effect of hypoxia on 
the chondrogenic differentiation of hATSC. 
Methods and Materials: In this attempt, hATSC were cultured for a 
30 day period either in 2D (monolayer) or in 3D (pellets), in control or 
chondrogenic medium and under low (5%) or normal (20%) oxygen 
tension. Cell differentiation was monitored at the level of mRNA by real-
time PCR. The production of sulfated glycosaminoglycans (GAG) and 
type II collagen were respectively determined by Alcian blue staining 
BOEJNNVOPIJTUPMPHJDBMEFUFDUJPOPOQBSBG¾OFNCFEEFEQFMMFUT
Results: Real-time PCR analysis indicated that type II collagen 
expression was markedly induced by hypoxia in both culture media. 
Aggrecan expression was induced by the presence of chondrogenic 
medium in 2 and 3D culture whatever the oxygen tension. Histological 
analysis showed the presence of sulfated GAG in chondrogenic medium 
whatever the oxygen tension. The presence of type II collagen in the 
matrix of pellets was detected only when hATSC were exposed to 
chondrogenic medium and hypoxic condition. 
Conclusions: Our results highlight the major role of hypoxia and 3D 
environment in the chondrogenic differentiation of hATSC. Whether our 
¾OEJOHTNBZCFQSPNJTJOHGPSUIFDFMMCBTFEUIFSBQZPGDBSUJMBHFTIPVME
be paid further attention.
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Pharmacological regulation of adult stem cells: Chondrogenesis 
can be induced using a synthetic inhibitor of the retinoic acid 
receptor
W. Kafienah1, S. Mistry2, M.J. Perry3, G. Politopoulou3,
A.P. Hollander4;
1Academic Rheumatology, University of Bristol, Bristol, United 
Kingdom, 2Department Of Clinical Science At North Bristol, University 
of Bristol, Bristol, United Kingdom, 3Clinical Science At North 
Bristol, University of Bristol, Bristol, United Kingdom, 4Department
Of Clinical Science At North Bristol, University of Bristol Academic 
Rheumatology, Bristol, United Kingdom
Purpose: The use of adult stem cells for the repair of cartilage lesions 
SFRVJSFTXFMMEF¾OFEBOEFG¾DJFOUQSPUPDPMTGPSEJSFDUJOHUIFEJGGFSFOUJBUJPO
of stem cells into the chondrogenic lineage. This process currently relies 
on growth factors that lead to hypertrophy. We have investigated the 
possibility of using pharmacological manipulation of adult human stem 
cells by determining which, if any, of the nuclear receptor superfamily 
might be involved in chondrogenesis. 
Methods and Materials: Bone marrow mesenchymal stem cells (BMSCs) 
from osteoarthritis patients were analysed using RT-PCR and FACS for 
the expression of nuclear receptor superfamily in monolayer and after 
chondrogenic differentiation with TGF-ȕ3. Based on this analysis, a synthetic 
inhibitor of the RAR ȕ receptor (LE135) was used to induce chondrogenic 
differentiation in 2D and 3D cultures of BMSCs. The chondrogenic tissue 
was analysed by quantitative RT-PCR and immunoassays. The signalling 
pathway was analysed by siRNA knockdown of SOX9. 
Results: Undifferentiated BMSCs expressed all variants of PPAR, RXR and RARs 
with little or no RAR Ȗ expression. After chondrogenic stimulation in 3D culture 
with TGF-ȕ, there was a clear downregulation of RAR ȕ expression. Incubation 
of BMSCs with LE135 in monolayer or 3D cultures revealed increased aggrecan 
and type II collagen mRNA and protein content that matched stimulation with 
TGF-ȕ. SOX9 and type X collagen mRNA was barely detected in LE135 cartilage 
constructs. SOX9 siRNA knock down inhibited chondrogenesis in TGF-ȕ
stimulated monolayer cultures but not in LE135 cultures. 
Conclusions: These results demonstrate the feasibility of a pharmacological 
approach to the regulation of stem cell function. 
